GI-129471

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameGI-129471
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionMetalloproteases inhibitorsTumor necrosis factor inhibitorsPeptide hydrolase inhibitors
TargetsPeptide hydrolaseMetalloproteasesTumor necrosis factor
Therapy Area/IndicationsShock, Septic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsShock, Septic

Other Information

ATC CodeN/A
Related LinksN/A